Volume 6, Number 5—October 2000
Molecular Characterization of Mycobacterium Abscessus Strains Isolated from a Hospital Outbreak
Highlight and copy the desired format.
|EID||Raman LA, Siddiqi N, Shamim M, Deb M, Mehta G, Hasnain SE, et al. Molecular Characterization of Mycobacterium Abscessus Strains Isolated from a Hospital Outbreak. Emerg Infect Dis. 2000;6(5):561-562. https://dx.doi.org/10.3201/eid0605.000524|
|AMA||Raman LA, Siddiqi N, Shamim M, et al. Molecular Characterization of Mycobacterium Abscessus Strains Isolated from a Hospital Outbreak. Emerging Infectious Diseases. 2000;6(5):561-562. doi:10.3201/eid0605.000524.|
|APA||Raman, L. A., Siddiqi, N., Shamim, M., Deb, M., Mehta, G., & Hasnain, S. E. (2000). Molecular Characterization of Mycobacterium Abscessus Strains Isolated from a Hospital Outbreak. Emerging Infectious Diseases, 6(5), 561-562. https://dx.doi.org/10.3201/eid0605.000524.|
To the Editor: In recent years there have been several reports of sporadic and epidemic hospital-acquired infections caused by rapidly growing mycobacteria, namely, Mycobacterium abscessus, M. chelonae, and M. fortuitum. M. abscessus has been well documented as a cause of cutaneous and soft tissue infections and has been implicated in chronic ear infections, bacteremia associated with hemodialysis equipment, and peritoneal dialysis-related infections (1).
Differentiating mycobacteria to the species level is difficult because of the diversity of available techniques and the time required for full identification. A rapid method based on the evaluation of the gene coding for the 65-kDa heat shock protein, which contains epitopes unique and common to various species of mycobacteria, has been reported (2). A 383-bp sequence situated at the amino terminus of this 65-kDa antigen (3) has been shown to be conserved among several species of mycobacteria. Reports based on polymerase chain reaction (PCR) amplification and DNA sequencing (4) show species-specific polymorphism at the nucleotide level within this region (5). The conserved nature of this gene allows differentiation of mycobacteria within 1 day by restriction enzyme digestion of PCR products obtained by using primers common to all mycobacteria.
From August 1995 through December 1995, postoperative wound infections developed in 45 patients in the pediatric surgery unit of Kalawati Saran Children's Hospital, New Delhi, India; 42 were day-care patients, and 3 were inpatients who had undergone major surgery. Thirty-two clinical samples (pus and exudate) were tested for acid-fast bacilli by the Ziehl-Neelson method; the same smear samples were cultured on Lowenstein-Jensen slants and examined for growth daily for 4 days and thereafter twice a week for 8 weeks. The organism was identified biochemically (i.e., by the niacin and nitrate production test) as M. abscessus.
The genomic DNA from the culture of mycobacterial isolates was extracted by standardized protocol (6) and subjected to PCR-restriction enzyme pattern analysis (PRA) (2). Primers TB11 (5-ACC AAC GAT GGG GTG TGT CCA T) and TB12 (5′-CTT GTC GAA CCG CAT ACC CT) amplified a 439-bp fragment between positions 398 and 836 of the published gene sequence for 65-kDa heat shock protein (3). The PCR products were then digested separately by using restriction enzymes Bst EII and HaeIII. The digests were fractionated on nondenaturing 10% polyacrylamide gel. The Bst EII pattern generated during PRA yielded two 235/210-bp bands similar to the patterns attributed to M. chelonae subsp. abscessus (2). The patterns displayed on HaeIII digestion had distinctive 150/60-bp bands that were once again similar to the pattern attributed to M. chelonae subsp. abscessus (2). PRA results confirmed that the isolates were M. abscessus. The source of the outbreak was traced to the tap water in the operating room and to a defective autoclaving process (the result of a leaking vacuum pump and faulty pressure gauge in the autoclave).
This report highlights the role of rapidly growing mycobacteria in a water-related nosocomial outbreak. The PCR-PRA method promises to be a very rapid, economical and universal system of identifying mycobacteria to the species level. This technique does not require hybridization to a panel of species-specific probes, which is a limitation of other PCR-based and hybridization methods for differentiating mycobacterial species. This method has the potential to be a useful diagnostic as well as epidemiologic marker for typing isolates of most mycobacteria during institutional outbreaks.
- Hakim A, Hisam N, Reuman PD. Environmental mycobacterial peritonitis complicating peritoneal dialysis: three cases and review. Clin Infect Dis. 1993;16:426–31.
- Telenti A, Marchesi F, Balz M, Baally F, Bottger EC, Bodmer T. Rapid identification of Mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175–8.
- Shinnick T. The 65-kilodalton antigen of Mycobacterium tuberculosis. J Bacteriol. 1987;169:1080–8.
- Brisson-Noel A, Aznar C, Chureau C, Nguyen S, Pierre C, Bartoli M, Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet. 1991;338:364–6.
- Hance A, Grandchamp B, Levy-Frebaault V, Lecossier D, Rauzier JJ, Bocart D, Detection and identification of mycobacteria by amplification of mycobacterial DNA. Mol Microbiol. 1989;3:843–9.
- Siddiqi N, Shamim M, Jain NK, Rattan A, Amin A, Katoch VM, Molecular anaylsis of multi-drug resistance in Indian isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz. 1998;3:589–94.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 17, 2010
- Page last updated: December 17, 2010
- Page last reviewed: December 17, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)